Related Experiment Video
Updated: May 10, 2026
12:40
Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
Thinking outside the liver: induced pluripotent stem cells for hepatic applications
Mekala Subba Rao1, Mitnala Sasikala, D Nageshwar Reddy
1Institute of Basic Sciences and Translational Research, Asian Healthcare Foundation, Asian Institute of Gastroenterology, Hyderabad 500082, India.
World Journal of Gastroenterology
|June 27, 2013
Summary
Induced pluripotent stem cells (iPSCs) offer an ethical alternative to embryonic stem cells for regenerative medicine. These reprogrammed somatic cells can generate hepatocytes for disease modeling and personalized therapies.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Hepatology
Background:
- Human embryonic stem cells (hESCs) face ethical and immune rejection challenges.
- Induced pluripotent stem cells (iPSCs) offer an alternative by reprogramming somatic cells.
- iPSCs overcome ethical concerns and immune rejection associated with hESCs.
Purpose of the Study:
- To review the generation, characterization, and differentiation of iPSCs into hepatocytes.
- To explore the potential applications of iPSC-derived hepatocytes in disease modeling and cell therapy.
- To discuss liver stem cells and their role in liver regeneration.
Main Methods:
- Review of scientific literature on iPSC induction and reprogramming factors.
- Analysis of iPSC characterization techniques.
- Examination of hepatocyte differentiation protocols and applications.
Main Results:
- iPSCs can be generated from somatic cells using specific reprogramming factors.
- iPSCs can differentiate into functional hepatocytes under controlled conditions.
- iPSC-derived hepatocytes hold promise for disease modeling, drug screening, and autologous cell therapies.
Conclusions:
- iPSCs represent a significant advancement, overcoming ethical and immunological barriers in stem cell therapy.
- iPSC-derived hepatocytes offer a scalable and potentially personalized source for liver-related applications.
- Despite concerns like tumorigenicity, iPSCs present a promising avenue for future clinical translation in liver regeneration and disease treatment.
Related Concept Videos
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...